Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis.

[1]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[2]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[3]  J. Ioannidis,et al.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. , 2001, JAMA.

[4]  S. Yusuf,et al.  Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis , 2000, The Lancet.

[5]  L. Z.  How do Cochrane reviewers address adverse effects of drug therapy , 2000 .

[6]  Alexa T. McCray,et al.  Application of Technology: Design and Implementation of a National Clinical Trials Registry , 2000, J. Am. Medical Informatics Assoc..

[7]  J. Lau,et al.  State of the evidence: current status and prospects of meta-analysis in infectious diseases. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. First,et al.  The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis. , 1999, Transplantation.

[9]  C. Schmid,et al.  Safety of nifedipine in angina pectoris: a meta-analysis. , 1999, Hypertension.

[10]  J. Ioannidis,et al.  Reporting of safety data from randomised trials , 1998, The Lancet.

[11]  S. D. de Ferranti,et al.  Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis , 1998, BMJ.

[12]  W. Stalman,et al.  The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial. , 1997, The British journal of general practice : the journal of the Royal College of General Practitioners.

[13]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[14]  Kenneth F. Schulz,et al.  The CONSORT Statement , 1996 .

[15]  D. Rennie,et al.  The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. , 1995, JAMA.

[16]  Les M Irwig,et al.  An evidence based approach to individualising treatment , 1995, BMJ.

[17]  L. Stewart,et al.  Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.

[18]  J. Berlin,et al.  Meta‐analysis of randomized controlled trials as a method of estimating rare complications of non‐steroidal anti‐inflammatory drug therapy , 1988, Alimentary pharmacology & therapeutics.

[19]  R. Simes.  Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[21]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.